Euroapi SAS
PAR:EAPI
Euroapi SAS
Net Issuance of Common Stock
Euroapi SAS
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Net Issuance of Common Stock
-€100k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Net Issuance of Common Stock
-€347m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
|
|
Ipsen SA
PAR:IPN
|
Net Issuance of Common Stock
-€36.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-2%
|
|
|
Vetoquinol SA
PAR:VETO
|
Net Issuance of Common Stock
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Virbac SA
PAR:VIRP
|
Net Issuance of Common Stock
-€19.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medincell SA
PAR:MEDCL
|
Net Issuance of Common Stock
€316k
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Net Issuance of Common Stock?
Net Issuance of Common Stock
-100k
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Net Issuance of Common Stock amounts to -100k EUR.
What is Euroapi SAS's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
83%
Over the last year, the Net Issuance of Common Stock growth was 83%.
You don't have any saved screeners yet